vs
CSW INDUSTRIALS, INC.(CSW)与Orion Group Holdings Inc(ORN)财务数据对比。点击上方公司名可切换其他公司
CSW INDUSTRIALS, INC.的季度营收约是Orion Group Holdings Inc的1.1倍($233.0M vs $216.3M),CSW INDUSTRIALS, INC.净利率更高(4.4% vs 2.2%,领先2.2%),CSW INDUSTRIALS, INC.同比增速更快(20.3% vs 14.6%),过去两年Orion Group Holdings Inc的营收复合增速更高(6.1% vs 5.1%)
奥里昂集团是源自芬兰的全球化制药企业,1917年成立,总部位于芬兰埃斯波。公司面向全球市场研发、生产并销售人用与兽用药品以及药用活性成分,旗下全部生产基地与大部分研发部门均设立在芬兰。
CSW vs ORN — 直观对比
营收规模更大
CSW
是对方的1.1倍
$216.3M
营收增速更快
CSW
高出5.7%
14.6%
净利率更高
CSW
高出2.2%
2.2%
两年增速更快
ORN
近两年复合增速
5.1%
损益表 — Q3 FY2026 vs Q1 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $233.0M | $216.3M |
| 净利润 | $10.3M | $4.7M |
| 毛利率 | 39.7% | 12.0% |
| 营业利润率 | 7.4% | — |
| 净利率 | 4.4% | 2.2% |
| 营收同比 | 20.3% | 14.6% |
| 净利润同比 | -61.9% | 435.7% |
| 每股收益(稀释后) | $0.62 | $0.12 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
CSW
ORN
| Q1 26 | — | $216.3M | ||
| Q4 25 | $233.0M | $233.2M | ||
| Q3 25 | $277.0M | $225.1M | ||
| Q2 25 | $263.6M | $205.3M | ||
| Q1 25 | $230.5M | $188.7M | ||
| Q4 24 | $193.6M | $216.9M | ||
| Q3 24 | $227.9M | $226.7M | ||
| Q2 24 | $226.2M | $192.2M |
净利润
CSW
ORN
| Q1 26 | — | $4.7M | ||
| Q4 25 | $10.3M | $-240.0K | ||
| Q3 25 | $40.7M | $3.3M | ||
| Q2 25 | $40.9M | $841.0K | ||
| Q1 25 | $35.1M | $-1.4M | ||
| Q4 24 | $26.9M | $6.8M | ||
| Q3 24 | $36.1M | $4.3M | ||
| Q2 24 | $38.6M | $-6.6M |
毛利率
CSW
ORN
| Q1 26 | — | 12.0% | ||
| Q4 25 | 39.7% | 11.6% | ||
| Q3 25 | 43.0% | 13.2% | ||
| Q2 25 | 43.8% | 12.6% | ||
| Q1 25 | 44.2% | 12.2% | ||
| Q4 24 | 41.4% | 14.0% | ||
| Q3 24 | 45.6% | 11.9% | ||
| Q2 24 | 47.5% | 9.5% |
营业利润率
CSW
ORN
| Q1 26 | — | — | ||
| Q4 25 | 7.4% | 2.2% | ||
| Q3 25 | 20.5% | 2.4% | ||
| Q2 25 | 20.8% | 1.7% | ||
| Q1 25 | 19.5% | 0.4% | ||
| Q4 24 | 15.3% | 4.4% | ||
| Q3 24 | 22.6% | 3.4% | ||
| Q2 24 | 24.3% | -1.4% |
净利率
CSW
ORN
| Q1 26 | — | 2.2% | ||
| Q4 25 | 4.4% | -0.1% | ||
| Q3 25 | 14.7% | 1.5% | ||
| Q2 25 | 15.5% | 0.4% | ||
| Q1 25 | 15.2% | -0.7% | ||
| Q4 24 | 13.9% | 3.1% | ||
| Q3 24 | 15.8% | 1.9% | ||
| Q2 24 | 17.1% | -3.4% |
每股收益(稀释后)
CSW
ORN
| Q1 26 | — | $0.12 | ||
| Q4 25 | $0.62 | $-0.00 | ||
| Q3 25 | $2.41 | $0.08 | ||
| Q2 25 | $2.43 | $0.02 | ||
| Q1 25 | $2.05 | $-0.04 | ||
| Q4 24 | $1.60 | $0.22 | ||
| Q3 24 | $2.26 | $0.12 | ||
| Q2 24 | $2.47 | $-0.20 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $40.2M | $6.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.1B | $166.7M |
| 总资产 | $2.3B | $478.7M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
CSW
ORN
| Q1 26 | — | $6.3M | ||
| Q4 25 | $40.2M | $1.6M | ||
| Q3 25 | $31.5M | $4.9M | ||
| Q2 25 | $38.0M | $1.7M | ||
| Q1 25 | $225.8M | $13.0M | ||
| Q4 24 | $213.8M | $28.3M | ||
| Q3 24 | $273.2M | $28.3M | ||
| Q2 24 | $18.9M | $4.8M |
总债务
CSW
ORN
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $33.4M | ||
| Q1 25 | $800.1M | $23.3M | ||
| Q4 24 | — | $23.2M | ||
| Q3 24 | — | $28.0M | ||
| Q2 24 | — | $60.3M |
股东权益
CSW
ORN
| Q1 26 | — | $166.7M | ||
| Q4 25 | $1.1B | $159.0M | ||
| Q3 25 | $1.1B | $157.9M | ||
| Q2 25 | $1.1B | $153.2M | ||
| Q1 25 | $1.1B | $150.8M | ||
| Q4 24 | $1.0B | $150.7M | ||
| Q3 24 | $1.0B | $142.4M | ||
| Q2 24 | $650.2M | $111.1M |
总资产
CSW
ORN
| Q1 26 | — | $478.7M | ||
| Q4 25 | $2.3B | $414.7M | ||
| Q3 25 | $1.5B | $422.4M | ||
| Q2 25 | $1.5B | $432.7M | ||
| Q1 25 | $1.4B | $416.3M | ||
| Q4 24 | $1.4B | $417.3M | ||
| Q3 24 | $1.4B | $430.3M | ||
| Q2 24 | $1.1B | $414.0M |
负债/权益比
CSW
ORN
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.22× | ||
| Q1 25 | 0.75× | 0.15× | ||
| Q4 24 | — | 0.15× | ||
| Q3 24 | — | 0.20× | ||
| Q2 24 | — | 0.54× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $28.9M | — |
| 自由现金流经营现金流 - 资本支出 | $22.7M | — |
| 自由现金流率自由现金流/营收 | 9.8% | — |
| 资本支出强度资本支出/营收 | 2.6% | — |
| 现金转化率经营现金流/净利润 | 2.81× | — |
| 过去12个月自由现金流最近4个季度 | $162.0M | — |
8季度趋势,按日历期对齐
经营现金流
CSW
ORN
| Q1 26 | — | — | ||
| Q4 25 | $28.9M | $13.8M | ||
| Q3 25 | $61.8M | $23.3M | ||
| Q2 25 | $60.6M | $-5.6M | ||
| Q1 25 | $27.3M | $-3.4M | ||
| Q4 24 | $11.6M | $13.4M | ||
| Q3 24 | $66.8M | $37.5M | ||
| Q2 24 | $62.7M | $-15.3M |
自由现金流
CSW
ORN
| Q1 26 | — | — | ||
| Q4 25 | $22.7M | $454.0K | ||
| Q3 25 | $58.7M | $13.9M | ||
| Q2 25 | $57.7M | $-12.7M | ||
| Q1 25 | $22.8M | $-12.5M | ||
| Q4 24 | $8.5M | $9.9M | ||
| Q3 24 | $61.3M | $33.3M | ||
| Q2 24 | $59.6M | $-20.0M |
自由现金流率
CSW
ORN
| Q1 26 | — | — | ||
| Q4 25 | 9.8% | 0.2% | ||
| Q3 25 | 21.2% | 6.2% | ||
| Q2 25 | 21.9% | -6.2% | ||
| Q1 25 | 9.9% | -6.6% | ||
| Q4 24 | 4.4% | 4.6% | ||
| Q3 24 | 26.9% | 14.7% | ||
| Q2 24 | 26.3% | -10.4% |
资本支出强度
CSW
ORN
| Q1 26 | — | — | ||
| Q4 25 | 2.6% | 5.7% | ||
| Q3 25 | 1.1% | 4.2% | ||
| Q2 25 | 1.1% | 3.5% | ||
| Q1 25 | 2.0% | 4.8% | ||
| Q4 24 | 1.6% | 1.6% | ||
| Q3 24 | 2.4% | 1.8% | ||
| Q2 24 | 1.4% | 2.4% |
现金转化率
CSW
ORN
| Q1 26 | — | — | ||
| Q4 25 | 2.81× | — | ||
| Q3 25 | 1.52× | 7.05× | ||
| Q2 25 | 1.48× | -6.61× | ||
| Q1 25 | 0.78× | — | ||
| Q4 24 | 0.43× | 1.98× | ||
| Q3 24 | 1.85× | 8.79× | ||
| Q2 24 | 1.62× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CSW
| Contractor Solutions Segment | $166.3M | 71% |
| Specialized Reliability Solutions Segment | $38.2M | 16% |
| Engineered Building Solutions Segment | $28.5M | 12% |
ORN
暂无分部数据